XBOM
HSIL
Market cap43mUSD
Nov 12, Last price
296.00INR
Name
H S India Ltd
Chart & performance
P/E
23.28
P/S
1.83
EPS
12.72
Div yield, %
—
Shrs. gr., 5y
3.12%
Rev. gr., 5y
31.14%
Revenues
2.32b
+117.38%
Net income
182m
+126.23%
CFO
-343m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hemant Surgical Industries Ltd. functions as a pharmaceutical enterprise, focusing on the import, production, and distribution of both surgical equipment and pharmaceutical items. Hanskumar Shamji Shah established the firm in 1985, and its primary operations are based in Mumbai, India.
Key people
Pushpendra Bansal
Chief Executive Officer, Managing Director, Director · since 2022
Ramesh Bansal
Chief Financial Officer, Managing Director, Executive Director · since 2017
Hitesh Limbani
Compliance Officer, Company Secretary · since 2013
Nilkanth Barot
Additional Director · since 2015
Mehul Hingu
Independent Director · since 2024
Adityabhai Joshi
Independent Director · since 2022
Ghanshyam Mistry
Independent Director · since 2022
Headquarters & legal address
UNIT NO. 202, MORYA BLUE MOON,
OFF NEW LINK ROAD,
ANDHERI WEST,
MUMBAI, MH 400053
IN
OFF NEW LINK ROAD,
ANDHERI WEST,
MUMBAI, MH 400053
IN
Valuation
Title INR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||